Novel estrogen receptor ligands and method III

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20040082642A1
SERIAL NO

10433271

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to compounds of formula (I) and derivatives thereof, in which the variables are as defined in the claims, their synthesis, and their use as estrogen receptor modulators. The compounds of the instant invention are ligands for estrogen receptors and as such may be useful for treatment or prevention of a variety of conditions related to estrogen functioning including bone loss, bone fractures, osteoporosis, cartilage degeneration, endometriosis, uterine fibroid disease, hot flashes, increased levels of LDL cholesterol, cardiovascular disease, impairment of cognitive functioning, cerebral degenerative disorders, restinosis, gynecomastia, autoimmune disease, vascular smooth muscle cell profileration, obesity, incontinence, and cancer of the lung, colon, breast, uterus, and prostate.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MERCK & CO INCP O BOX 2000 RY60-30 RAHWAY NJ 07065-0907
KARO BIO ABNOVUM SE-141 57 HUDDINGE

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Cheng, Aiping Huddinge, SE 12 50
Gillner, Mikael Stockholm, SE 4 28
Hammond, Milton Lloyd Somerville, NJ 3 12
Heck, James V Rahway, NJ 34 254
Koehler, Konrad Huddinge, SE 9 30
Liu, Ye Tullinge, SE 322 2208
Mosley, Ralph Troy Rahway, NJ 2 5
Rahimi-Ghadim, Mahmoud Stockholm, SE 3 5

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation